company background image
KAEF logo

Kimia Farma IDX:KAEF Stock Report

Last Price

Rp660.00

Market Cap

Rp3.7t

7D

9.1%

1Y

12.8%

Updated

16 Jun, 2025

Data

Company Financials

KAEF Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

PT Kimia Farma Tbk Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kimia Farma
Historical stock prices
Current Share PriceRp660.00
52 Week HighRp905.00
52 Week LowRp324.00
Beta2
1 Month Change42.86%
3 Month Change54.93%
1 Year Change12.82%
3 Year Change-51.82%
5 Year Change-42.86%
Change since IPO214.29%

Recent News & Updates

Recent updates

Shareholder Returns

KAEFID PharmaceuticalsID Market
7D9.1%-2.7%1.0%
1Y12.8%3.0%6.5%

Return vs Industry: KAEF exceeded the ID Pharmaceuticals industry which returned 3% over the past year.

Return vs Market: KAEF exceeded the ID Market which returned 6.5% over the past year.

Price Volatility

Is KAEF's price volatile compared to industry and market?
KAEF volatility
KAEF Average Weekly Movement13.4%
Pharmaceuticals Industry Average Movement7.6%
Market Average Movement7.2%
10% most volatile stocks in ID Market14.2%
10% least volatile stocks in ID Market3.6%

Stable Share Price: KAEF's share price has been volatile over the past 3 months compared to the ID market.

Volatility Over Time: KAEF's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of ID stocks.

About the Company

FoundedEmployeesCEOWebsite
181710,712n/akimiafarma.co.id

PT Kimia Farma Tbk engages in the manufacturing and sale of pharmaceutical products in Indonesia. It also provides generic, ethical, license and narcotic medicines, over the counter medicines, raw materials, medicines, medical devices, and cosmetic products, as well as rapid test diagnostic tools. In addition, the company is involved manufacturing and marketing of pharmaceutical raw materials and active pharmaceutical ingredients; health foods and effervescent tablets; quinine salt and related derivatives; and castor oil and edible oil.

PT Kimia Farma Tbk Fundamentals Summary

How do Kimia Farma's earnings and revenue compare to its market cap?
KAEF fundamental statistics
Market capRp3.67t
Earnings (TTM)-Rp1.71t
Revenue (TTM)Rp10.11t
0.4x
P/S Ratio
-2.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KAEF income statement (TTM)
RevenueRp10.11t
Cost of RevenueRp7.82t
Gross ProfitRp2.30t
Other ExpensesRp4.01t
Earnings-Rp1.71t

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-307.30
Gross Margin22.69%
Net Profit Margin-16.91%
Debt/Equity Ratio133.5%

How did KAEF perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/16 00:56
End of Day Share Price 2025/06/16 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PT Kimia Farma Tbk is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alvin GunawanCGS International
Janni AsmanMaybank Research Pte. Ltd.
Michael SetjoadiPT Bahana Securities